| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |